Precision AQ
Evidence Solutions is a global healthcare market access consultancy that focuses on addressing issues related to healthcare market dynamics, product value, pricing, and access. They are seeking motivated consultants who are analytical, detail-oriented, and capable of developing client-focused solutions in a dynamic environment.
Precision AQ is a healthcare access and commercialization firm focused on empowering access to life‑changing medicines. With a team of more than 1,200 experts, it partners with biopharma and healthcare organizations to design and implement strategies that improve patient access, reimbursement, and product commercialization. The company combines commercial expertise, operational services, and technology-enabled solutions to streamline access pathways and drive adoption. Clients rely on Precision AQ for end-to-end programs that optimize launches and expand patient reach.
Precision AQ expands senior leadership team to strengthen global AI, data strategy, evidence synthesis and economic modelling capabilities
3 weeks ago
40 Under 40: Hannah Deresiewicz, Precision AQ
1 month ago
Precision AQ Invests in Phluence to Advance Next Generation of Agentic Patient Solutions
Nov 18, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Precision AQ.
Agency 100 2025: Precision AQ - MM+M
Jun 10, 2025
Consultant, Market Access
Precision for Medicine
Consultant, Market Access
Precision Medicine Group
Analyst, Market Access Consulting
Precision for Medicine
Market Access Communications Content and Copy Specialist
Blue Matter
Value, Access and Pricing Consultant
Initiate Systems
Consultant, Market Access
Precision Medicine Group